This text is a result of machine translation.
Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
4Paradigm Initiates IPO Today and Targets HKSE on September 28
Power Device Company Maplesemi Completes Series A+ Financing Round
Acoustic Technology Company Audfly Completes Series B Financing Round
Wicue Raised CNY 200 Mn in Series C+ Financing Round
Intelligent Industrial Drone and UAV Systems Developer I-KINGTEC Closed A Series C+ Financing Round
EqualOcean Weekly Hotspots Series (8/17-8/22)
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
Aug 22, 2025 11:25 AM
Meituan's Food Delivery Brand Keeta Launches in Qatar, Plans to Enter Brazil in Months
On August 19 (local time in Qatar), Keeta, the international food delivery brand under Chinese tech and retail giant Meituan, officially launched in Doha, the capital of Qatar. This marks another layout of Keeta in the Middle East market following its entry into Saudi Arabia.
Aug 20, 2025 06:44 PM
Em-Data Technology Completed Strategic Financing Round
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
Chinese medicine stocks recovered significantly in the afternoon
Pharmaceutical and biological stocks continued to strengthen in the afternoon
State Food and Drug Administration: Yitong Biotechnology (Guangzhou) Co., Ltd. stopped production for rectification